hiw3c 日报精选
TechCrunch AI 网页快照

科学公司的脑科技在获得新资金后价值35亿美元。

原文标题 · Science Corporation’s brain tech is worth $3.5 billion after new funding

科学公司筹集了4亿美元的D轮资金,用于扩大其抗失明业务规模。

来源:TechCrunch AI · techcrunch.com

正文为英文,可一键机器翻译(仅首次需要等待)

Science Corporation’s brain tech is worth $3.5 billion after new funding

Science Corporation , the medical technology startup founded by former Neuralink president Max Hodak in 2021, raised a $400 million Series D, the company said in a blog post .

Investors in the new round valued the company at $3.5 billion, a person familiar with the deal told TechCrunch. Those backers included Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech.

Hodak, who talked his way into a graduate neuroscience lab as a college student and has pursued biotechnology ever since, co-founded Science to leverage new technologies to understand and interact with the brain.

Science’s first product is PRIMA, a wearable and implantable chip that helps people with age-related macular degeneration recover some vision. The device is approved in Europe and available in Germany, as well as being trialed for new conditions.

Hodak announced that the device is now being trialed for patients with another blindness-causing condition, Stargardt disease, while onstage at TechCrunch Disrupt.

With the funding, the company aims to bring the device to the United States through the FDA’s Humanitarian Device Exemption, which lets experimental medical technology be used to treat rare conditions. Science has convinced the FDA that advanced macular degeneration in both eyes is uncommon enough to let them seek approval to use the device on people in the U.S.

Still, the startup’s big ambition and founding purpose is connecting directly to the human brain through a bio-hybrid sensor built from a combination of cultured neurons and silicon. The company is currently designing initial human trials of the device with Yale neurosurgery professor Murat Günel, who told TechCrunch it could offer potential treatments for Parkinson’s disease, among other brain injuries and illnesses.

Get an Early Peek at the Next TechCrunch Disrupt Disrupt, Startup Battlefield, and more will return next year, and you can be at the front of the line. Sign up for our waitlist

Newsletters

Subscribe for the industry’s biggest tech news

Related

AI Nvidia is abandoning China after Jensen Huang’s ouster Tim Fernholz

AI As decision model use skyrockets, is customization the next frontier? Tim Fernholz

Robotics Genesis AI raises $500M to deploy glove-wearing robots Tim Fernholz

Latest in Biotech & Health

In Brief Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials Ram Iyer

In Brief Science Corporation’s brain tech is worth $3.5 billion after new funding Tim Fernholz

Biotech & Health Upside Foods can now make a million pounds of chicken a year without killing any animals Amanda Silberling